Alto Neuroscience

About Alto Neuroscience

Alto Neuroscience is focused on leading innovation in psychiatric treatment by developing biology-driven medicines for neuropsychiatric conditions, aiming to help patients get better faster through a precision approach.

Products & Services

Clinical-Stage Drug Candidates:Designed to target core brain processes for neuropsychiatric conditions, with an initial focus on major depressive disorder, bipolar depression, and schizophrenia.

Precision Psychiatry Platform:An approach to predict clinical response and identify patients most likely to benefit from drug candidates by measuring brain biology.

Specialties

Precision Psychiatry Neuropsychiatric Drug Development CNS Drug Development and Commercialization Neurobiology Research

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 50000000 MR: - FA: approximately $50 million FAN: 50000000	D: 2025-10-20 FD: 2025-10-20	5 investors
2	RT: Grant T: - FT: Grant	A: 11700000 MR: - FA: $11.7 million FAN: 11700000	D: 2024-07-25 FD: 2024-07-25	1 investors
3	RT: Initial Public Offering (IPO) T: - FT: Initial Public Offering (IPO)	A: 147900000 MR: - FA: $147.9 million FAN: 147900000	D: 2024-02-06 FD: 2024-02-06	5 investors
4	RT: Initial Public Offering (IPO) T: - FT: Initial Public Offering (IPO)	A: 128600000 MR: - FA: $128.6 million FAN: 128600000	D: 2024-02-01 FD: 2024-02-01	5 investors
5	RT: Series C T: - FT: Series C	A: 45000000 MR: - FA: 45 million FAN: 45000000	D: 2023-11-21 FD: 2023-11-21	10 investors
6	RT: Series B T: - FT: Series B	A: 60000000 MR: - FA: $60 million FAN: 60000000	D: 2023-01-30 FD: 2023-01-30	2 investors

Private Placement Latest

2025-10-20

$50.0M

5 investors (Pro only)

Grant 2024-07-25

$11.7M

Initial Public Offering (IPO) 2024-02-06

$147.9M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Amit Etkin

Founder, President, and Chief Executive Officer

M

Michael Hanley

Chief Operating Officer

E

Erin R. McQuade

General Counsel and Chief Administrative Officer

J

Jessica Powell

Chief Development Officer

A

Adam Savitz

Chief Medical Officer

N

Nick Smith

Chief Financial Officer and Chief Business Officer

View 15 more team members with Pro

Unlock Full Team Directory

Recent News